溴哌利多结构式
|
常用名 | 溴哌利多 | 英文名 | Bromperidol |
|---|---|---|---|---|
| CAS号 | 10457-90-6 | 分子量 | 420.31500 | |
| 密度 | 1.366 g/cm3 | 沸点 | 543.6ºC at 760 mmHg | |
| 分子式 | C21H23BrFNO2 | 熔点 | 156-158ºC | |
| MSDS | N/A | 闪点 | 282.6ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
溴哌利多用途Bromperidol是一种丁酰苯类衍生物,是一种强效且长效的抗精神病药,用于治疗精神分裂症。 |
| 中文名 | 溴哌利多 |
|---|---|
| 英文名 | Bromperidol |
| 中文别名 | 溴哌醇 |
| 英文别名 | 更多 |
| 密度 | 1.366 g/cm3 |
|---|---|
| 沸点 | 543.6ºC at 760 mmHg |
| 熔点 | 156-158ºC |
| 分子式 | C21H23BrFNO2 |
| 分子量 | 420.31500 |
| 闪点 | 282.6ºC |
| 精确质量 | 419.09000 |
| PSA | 40.54000 |
| LogP | 4.47260 |
| 外观性状 | 黄褐色固体 |
| 蒸汽压 | 1.19E-12mmHg at 25°C |
| 折射率 | 1.59 |
| 储存条件 | 库房通风低温干燥,与食品原料类分开存放 |
| 水溶解性 | H2O: insoluble |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302 |
| 警示性声明 | P301 + P312 + P330 |
| 危害码 (欧洲) | Xn |
| 风险声明 (欧洲) | 22 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
| RTECS号 | EU1180000 |
| 海关编码 | 2933399090 |
|
~58%
溴哌利多 10457-90-6 |
| 文献：Vincent; Shambhu; Digenis Journal of medicinal chemistry, 1980 , vol. 23, # 1 p. 75 - 79 |
|
~78%
溴哌利多 10457-90-6 |
| 文献：Moerlein, Stephen M.; Stoecklin, Gerhard L. Journal of Medicinal Chemistry, 1985 , vol. 28, # 9 p. 1319 - 1324 |
| 溴哌利多上游产品 1 | |
|---|---|
| 溴哌利多下游产品 1 | |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC–MS/MS: Application on postmortem samples
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 970 , 1-7, (2014) • The introduction has been modified. • More references have been added to the text. • Limitations of the method have been discussed more in detail. |
|
|
Sensitive determination of 4-(4-bromophenyl)-4-hydroxypiperidine, a metabolite of bromperidol, in rat plasma by HPLC with fluorescence detection after pre-column derivatization using 4-fluoro-7-nitro-2,1,3-benzoxadiazole.
Biol. Pharm. Bull. 29(12) , 2479-82, (2006) The purpose of this study was to determine the level of 4-(4-bromophenyl)-4-hydroxypiperidine (BPHP), a bromperidol (BRO) metabolite, in rat plasma by HPLC with fluorescence detection after pre-column... |
|
|
Folie à deux: double case-report of shared delusions with a fatal outcome.
Clin. Ter. 162(1) , 45-9, (2011) Treatment of shared delusional disorder (folie à deux) often involves separation and use of antipsychotic medication, with uncertain outcomes and potential risks.We report on two highly interdependent... |
| MFCD00866670 |
| 4-(4-(4-Bromophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one |
| EINECS 233-943-3 |
| 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one |
![4-[4-hydroxy-4-(4-aminophenyl)piperidinyl]-1-(4-fluorophenyl)butanone结构式](https://www.chemsrc.com/caspic/176/114361-10-3.png)
CAS号366-77-8